Home
Images
Vectors
Videos
Stock image The nucleotide analogue remdesivir and the protease inhibitor camostat are potential drugs against Sars-CoV-2 infections..
Published:
Mar.16, 2020 14:13:32
Author:
animaxx3d
Views:
9
Downloads:
2
File type:
image
/
jpg
File size:
3.63 MB
Orginal size:
8000
x
6000
px
Available sizes:
S
(500 x 375)
M
(1000 x 750)
L
(2000 x 1500)
XL
(8000 x 6000)
EL0
(8000 x 6000)
Level:
bronze
Download Image
Image topics:
Virus
Drug
Molecule
Epidemic
Pandemic
Outbreak
Infection
Antiviral
Promising
Rna
Molecular Structure
Coronavirus
Prodrug
Covid
Remdesivir
Sars Cov 2
Formula Structure
Protease Inhibitor
Camostat
Nucleotide Analogue
Similar stock images
The Antiretroviral Protease Inhibitor Lopinavir Is Considered A Potential Drug Against Sars-CoV-2 Infections.
8000 × 6000
The Nucleoside Analog Remdesivir Is Considered A Promising Antiviral Drug For The Treatment Of Sars-CoV-2 Infections.. It Causes A Decrease In Viral RNA Production.
8000 × 6000
The Protease Inhibitor Camostat Is A Potential Candidate For The Treatment Of Sars-CoV-2 Infections.. It Blocks The Entry Of The Virus In Human Cells.
8000 × 6000
The Antimalaria Agent Chloroquine Is Considered A Potential Drug Against Sars-CoV-2 Infections..
8000 × 6000
Potential Drugs Against Coronavirus SARS-CoV-2 Infections. Clockwise From Upper Left: Remdesivir, Lopinavir, Camostat, Chloroquine
8000 × 6000
Structure Of Human Phosphodiesterase 5 Active Center Complexed With Tadalafil (blue), A Medicine For Erectile Dysfunction, 3D Model, Black Background
4096 × 4096
Neurotensin Neurotransmitter Peptide Molecule N DPC Micelles. It Exerts Multiple Biological Functions In The Central And Peripheral Nervous System
5842 × 3488
The Nucleotide Analog Remdesivir Blocks The SARS-CoV-2 RNA Dependent RNA Polymerase And Is A Promising Drug For The Treatment Of COVID-19. RdRp Is An Enzyme That Catalyzes The Replication Of RNA From An RNA Template. PDB Entry 7BTF
8000 × 6000